MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$10,963K
Net loss
-$10,345K
Deemed dividend
relating to warrant...
-$618K
Loss before tax
-$10,345K
Gain on sale of assets
$37K
Loss from operations
-$6,960K
Change in fair value of
warrant liability
$3,161K
Other
(expenses)/income, net
-$261K
Total costs and
expenses
$6,960K
General and
administrative
$6,875K
Research and development
$85K
Back
Back
Income Statement
source: myfinsight.com
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)